The HSP subfamily of HSP60 and the anti-HSP60 antibodies have been studied in patients with atherosclerosis, relating them to the disease severity and progression (Zhu et al., 2001; Damluji et al., 2015; Galović et al., 2016; Rodríguez-Iturbe and Johnson, 2018). This evidence concerns the gene HSP90B2P and atherosclerosis.